NDC 51662-1247
PROMETHAZINE HCI
Promethazine Hci
PROMETHAZINE HCI is a Intramuscular; Intravenous Injection in the Human Prescription Drug category. It is labeled and distributed by Hf Acquisition Co. Llc, Dba Healthfirst. The primary component is Promethazine Hydrochloride.
| Product ID | 51662-1247_7447e8c6-c199-cd2d-e053-2a91aa0a3895 |
| NDC | 51662-1247 |
| Product Type | Human Prescription Drug |
| Proprietary Name | PROMETHAZINE HCI |
| Generic Name | Promethazine Hci |
| Dosage Form | Injection |
| Route of Administration | INTRAMUSCULAR; INTRAVENOUS |
| Marketing Start Date | 2018-08-26 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA083312 |
| Labeler Name | HF Acquisition Co. LLC, DBA HealthFirst |
| Substance Name | PROMETHAZINE HYDROCHLORIDE |
| Active Ingredient Strength | 25 mg/mL |
| Pharm Classes | Phenothiazine [EPC],Phenothiazines [CS] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2019-12-31 |